In this study, we aimed to investigate the tendency of PD-L1 expression mechanism in CRC patients by determining its correlation with PD-L1 gene copy number status, tumour infiltrating lymphocytes (TILs), tumor mutational profile, as well as clinicopathologic features. This evidence concerns the gene CD274 and neoplasm.